Cajanin
CAS No. 32884-36-9
Cajanin ( —— )
产品货号. M30929 CAS No. 32884-36-9
Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥4040 | 有现货 |
|
| 50MG | 获取报价 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Cajanin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.
-
产品描述Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.
-
体外实验Cajanin shows strong mitogenic as well as differentiation-promoting effects on osteoblasts.Cajanin induces the phosphorylation of both Erk1/2 and Akt.
-
体内实验Cajanin (10 mg/kg, p.o.; daily for 30 consecutive days) increases the BMD levelsin all anatomical regions of the skeleton studied in Sprague Dawley rats.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number32884-36-9
-
分子量300.3
-
分子式C16H12O6
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
RC-3095 (TFA)
一种选择性蛙皮素 (bombesin)/胃泌素 (gastrin) 释放肽受体拮抗剂。RC-3095 TFA 作用于关节炎小鼠,通过减少胃氧化损伤来发挥保护作用。
-
Adrafinil
Adrafinil (CRL-40028, Olmifon)是modafinil的原药,是α-1肾上腺受体激动剂。
-
URAT1 inhibitor 7
URAT1 inhibitor 7 (compound 10f) 是一种有效的URAT1抑制剂,IC50为12 nM。URAT1 inhibitor 7 表现出微粒体稳定性(HLM <13 μL/min/mg)。URAT1 inhibitor 7 还抑制CYP2C9,IC50为4.2 μM。URAT1 inhibitor 7 可用于痛风研究。
021-51111890
购物车()
sales@molnova.cn

